News for June 2018

News Archive

The Current issue of “The view from here” is concerned with Therapeutics The Current issue of “The view from here” is concerned with Therapeutics

The topic of this month’s newsletter from Drug Discovery Today is “Therapeutics”

Turning A Phage Turning A Phage

Partnering with multiple institutions, UC San Diego launches North America’s first bacteriophage therapy center to use viruses as new weapon against multidrug-resistant bacteria; clinical trials planned

NHSA opens up £45bn Commonwealth life sciences economies to North NHSA opens up £45bn Commonwealth life sciences economies to North

THE Northern Health Science Alliance has signed a memorandum of understanding (MOU) with Life Sciences Queensland Limited (LSQ) in Australia and another MOU with SCAN Health and World Health Innovation (WIN) in Canada to open the door to working across the Commonwealth countries.

Cancer Research UK Tests First Of Its Kind Vaccine To Treat Lung Cancer Cancer Research UK Tests First Of Its Kind Vaccine To Treat Lung Cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer (NSCLC), under a collaboration agreement between Cancer Research UK and Asterias Biotherapeutics Inc.

University of Huddersfield launches Centre for Pharmaceutical Policy and Practice Research University of Huddersfield launches Centre for Pharmaceutical Policy and Practice Research

The pharmacy world has seen, and will continue to see, many advancements that will affect the industry and the way a pharmacy conducts its business. Now, a new research centre at the University of Huddersfield, will strive to ensure the industry is armed with the latest research methods and advice on policy and best practice.

The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery. The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism in Drug Discovery”.

UK Institute to harness disruptive technology to transform drug discovery UK Institute to harness disruptive technology to transform drug discovery

Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking drugs faster, cheaper and better than ever before. The projects are the first wave of major initiatives for the £103m Rosalind Franklin Institute, that was launched today at the Harwell Campus, Oxfordshire.

New research hub tackles the spread of new diseases New research hub tackles the spread of new diseases

The Centre for Process Innovation (CPI), the UK’s technology innovation provider for process manufacturing, has announced its involvement in the development of a new research hub aimed at delivering high-quality vaccines at low cost, with aims of preventing outbreaks of diseases such as Zika and Ebola.